Case Studies

An NIH study of treatments for high blood pressure, called the ALLHAT trial, shows some of the strengths and limitations of comparative effectiveness research to improve patient care. More...

Recent Blog Posts

February 3, 2012 |

On Tuesday night, PIPC Chairman Tony Coelho joined former HHS Secretary Tommy Thompson at the University of Charleston in West Virginia for a speaker series titled "Who Decides Patient Treatments" to discuss the future of health care in the United States.

| Read More
January 30, 2012 |

PCORI released a draft of their National Priorities for Research and Research Agenda for public comment. The PCORI Board, which is responsible for funding research, is asking for a 55 day public comment period to discuss and solicit feedback from patients, caregivers, professionals, and the general public on the research priorities.

In the draft, PCORI prioritized five broad research areas:

| Read More
October 18, 2011 |

When conducting Comparative Effectiveness Research it is crucial to understand the differences between the players involved in the process. In his remarks at the  2nd Annual Forum on Achieving Patient centeredness , Marc Boutin, executive vice president and COO at the National Health Council, discussed the important differences between the three major players in the process: the patient, the consumer, and the patient advocacy organization. He stated that many times when the patient is discussed they are not defined.

| Read More

For Reporters

For journalists and other media professionals

More Information

Stay Connected

PIPC Calls for Bipartisan Consensus on Patient-Centered Comparative Effectiveness

WASHINGTON, June 26, 2009 – After speaking at a health care reform event on comparative effectiveness research and choice in health care, Chairman of the Partnership to Improve Patient Care (PIPC), Tony Coelho, issued the following statement:
 
"The ability for patients and health care providers to get sound medical information to guide their treatment decisions is critically important.  Establishing comparative clinical effectiveness research to expand knowledge of what works in health care, while preserving the ability of doctors and patients to use this research to tailor care to the needs of the individual patient, is a vital part of health care reform.

“Comparative effectiveness research is not about dictating what kind of care should be provided. It's about providing patients and doctors with the information they need to make the best medical decisions.

"PIPC believes that bipartisan consensus to achieve this goal is within our reach and we commend both Democrats and Republicans on the Senate HELP Committee and the House Energy and Commerce Committee and Ways and Means Committee for taking the time to engage in a robust discussion of this important issue during recent hearings and mark-up of health care reform legislation.
 
"We urge lawmakers on both sides of the aisle to advance CER within the patient-centered framework established by Sens. Max Baucus (D-MT) and Kent Conrad (D-ND) and Rep. Kurt Schrader (D-OR) in their CER bills (S. 1213 and H.R. 2502).

"We also urge them to include strong patient safeguards in these bills to ensure that CER empowers patients and doctors with good information, and does not restrict access to appropriate medical care or impede their ability to select the tests and treatments that best meet the needs of the individual." 

At an event sponsored by the Alliance for Health Reform, Mr. Coelho highlighted the potential for CER to improve patient care, and emphasized the need for sound policy that centers on the needs of patients and providers and avoids misuse of CER in ways the deny patients' access to beneficial care.

Mr. Coelho said S. 1213 and H.R. 2502 offer a strong starting point for patient-centered CER and should be part of health care reform.

About PIPC
The Partnership to Improve Patient Care was formed in November 2008 to support new comparative effectiveness research proposals that are centered on patient and provider needs; raise awareness about the value of well-designed CER; and promote the important role of continued medical innovation as part of the solution to cost and quality challenges in health care. Partnership members include a wide range of healthcare organizations representing patient, provider and industry advocacy groups. 

###